These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 18810799

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy.
    Kim S, Youn H, Song MG, Kang JH, Chung HK, Lee DS, Chung JK.
    Cancer Gene Ther; 2012 Apr; 19(4):263-70. PubMed ID: 22301953
    [Abstract] [Full Text] [Related]

  • 6. Sodium-iodine symporter gene expression controlled by the EGR-1 promoter: biodistribution, imaging and in vitro radionuclide therapy with Na(131)I.
    Tang J, Wang X, Xu Y, Shi Y, Liu Z, Yang Y.
    Technol Cancer Res Treat; 2015 Feb; 14(1):61-9. PubMed ID: 24354753
    [Abstract] [Full Text] [Related]

  • 7. Use of rhenium-188 for in vivo imaging and treatment of human cervical cancer cells transfected with lentivirus expressing sodium iodide symporter.
    Zhang M, Shi S, Guo R, Miao Y, Li B.
    Oncol Rep; 2016 Oct; 36(4):2289-97. PubMed ID: 27573304
    [Abstract] [Full Text] [Related]

  • 8. Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.
    Kim YH, Youn H, Na J, Hong KJ, Kang KW, Lee DS, Chung JK.
    Theranostics; 2015 Oct; 5(1):86-96. PubMed ID: 25553100
    [Abstract] [Full Text] [Related]

  • 9. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
    Kang JH, Chung JK, Lee YJ, Shin JH, Jeong JM, Lee DS, Lee MC.
    J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
    [Abstract] [Full Text] [Related]

  • 10. Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter.
    Huang R, Zhao Z, Ma X, Li S, Gong R, Kuang A.
    Cancer Gene Ther; 2011 Feb; 18(2):144-52. PubMed ID: 21037556
    [Abstract] [Full Text] [Related]

  • 11. In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter.
    Kim HJ, Jeon YH, Kang JH, Lee YJ, Kim KI, Chung HK, Jeong JM, Lee DS, Lee MC, Chung JK.
    Cancer Biol Ther; 2007 Jul; 6(7):1130-5. PubMed ID: 17611400
    [Abstract] [Full Text] [Related]

  • 12. Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach.
    Riesco-Eizaguirre G, De la Vieja A, Rodríguez I, Miranda S, Martín-Duque P, Vassaux G, Santisteban P.
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1435-43. PubMed ID: 21697253
    [Abstract] [Full Text] [Related]

  • 13. Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy.
    Zhang M, Guo R, Shi S, Miao Y, Zhang Y, Li B.
    PLoS One; 2014 Sep; 9(3):e92326. PubMed ID: 24647588
    [Abstract] [Full Text] [Related]

  • 14. Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.
    Chai W, Yin X, Ren L, Cai M, Long T, Zhou M, Tang Y, Yang N, Hu S.
    Clin Transl Oncol; 2015 Oct; 17(10):795-802. PubMed ID: 26115738
    [Abstract] [Full Text] [Related]

  • 15. Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).
    Sieger S, Jiang S, Schönsiegel F, Eskerski H, Kübler W, Altmann A, Haberkorn U.
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):748-56. PubMed ID: 12541134
    [Abstract] [Full Text] [Related]

  • 16. Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (NIS) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cells.
    Tutter M, Schug C, Schmohl KA, Urnauer S, Schwenk N, Petrini M, Lokerse WJM, Zach C, Ziegler S, Bartenstein P, Weber WA, Wagner E, Lindner LH, Nelson PJ, Spitzweg C.
    Theranostics; 2020 May; 10(10):4490-4506. PubMed ID: 32292510
    [Abstract] [Full Text] [Related]

  • 17. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
    Knoop K, Schwenk N, Schmohl K, Müller A, Zach C, Cyran C, Carlsen J, Böning G, Bartenstein P, Göke B, Wagner E, Nelson PJ, Spitzweg C.
    J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085
    [Abstract] [Full Text] [Related]

  • 18. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
    Chen L, Altmann A, Mier W, Eskerski H, Leotta K, Guo L, Zhu R, Haberkorn U.
    J Nucl Med; 2006 May; 47(5):854-62. PubMed ID: 16644756
    [Abstract] [Full Text] [Related]

  • 19. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
    Shi S, Zhang M, Guo R, Miao Y, Hu J, Xi Y, Li B.
    PLoS One; 2015 May; 10(1):e0116531. PubMed ID: 25621996
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.